Treatment and Patient Selection for Patients with Metastatic Castration-resistant Prostate After Progression on Docetaxel and Abiraterone/Enzalutamide: When to Play Your CARD and When to Do Your PARP

被引:4
作者
Robinson, Andrew G. [1 ]
Izard, Jason P. [2 ]
Vera-Badillo, Francisco E. [1 ]
机构
[1] Queens Univ, Dept Oncol, Div Med Oncol, Kingston, ON, Canada
[2] Queens Univ, Dept Urol, Kingston, ON, Canada
关键词
OPEN-LABEL; CANCER; CABAZITAXEL; PREDNISONE; OLAPARIB; DEFECTS;
D O I
10.1016/j.eururo.2021.03.001
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:123 / 126
页数:4
相关论文
共 11 条
[1]   Rucaparib in Men With Metastatic Castration-Resistant Prostate Cancer Harboring a BRCA1 or BRCA2 Gene Alteration [J].
Abida, Wassim ;
Patnaik, Akash ;
Campbell, David ;
Shapiro, Jeremy ;
Bryce, Alan H. ;
McDermott, Ray ;
Sautois, Brieuc ;
Vogelzang, Nicholas J. ;
Bambury, Richard M. ;
Voog, Eric ;
Zhang, Jingsong ;
Piulats, Josep M. ;
Ryan, Charles J. ;
Merseburger, Axel S. ;
Daugaard, Gedske ;
Heidenreich, Axel ;
Fizazi, Karim ;
Higano, Celestia S. ;
Krieger, Laurence E. ;
Sternberg, Cora N. ;
Watkins, Simon P. ;
Despain, Darrin ;
Simmons, Andrew D. ;
Loehr, Andrea ;
Dowson, Melanie ;
Golsorkhi, Tony ;
Chowdhury, Simon .
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (32) :3763-+
[2]  
Beer TM, 2014, NEW ENGL J MED, V371, P424, DOI 10.1056/NEJMoa1405095
[3]   Olaparib for Metastatic Castration-Resistant Prostate Cancer [J].
de Bono, J. ;
Mateo, J. ;
Fizazi, K. ;
Saad, F. ;
Shore, N. ;
Sandhu, S. ;
Chi, K. N. ;
Sartor, O. ;
Agarwal, N. ;
Olmos, D. ;
Thiery-Vuillemin, A. ;
Twardowski, P. ;
Mehra, N. ;
Goessl, C. ;
Kang, J. ;
Burgents, J. ;
Wu, W. ;
Kohlmann, A. ;
Adelman, C. A. ;
Hussain, M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (22) :2091-2102
[4]   Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial [J].
de Bono, Johann Sebastian ;
Oudard, Stephane ;
Ozguroglu, Mustafa ;
Hansen, Steinbjorn ;
Machiels, Jean-Pascal ;
Kocak, Ivo ;
Gravis, Gwenaelle ;
Bodrogi, Istvan ;
Mackenzie, Mary J. ;
Shen, Liji ;
Roessner, Martin ;
Gupta, Sunil ;
Sartor, A. Oliver .
LANCET, 2010, 376 (9747) :1147-1154
[5]   Cabazitaxel versus Abiraterone or Enzalutamide in Metastatic Prostate Cancer [J].
de Wit, Ronald ;
de Bono, Johann ;
Sternberg, Cora N. ;
Fizazi, Karim ;
Tombal, Bertrand ;
Wuelfing, Christian ;
Kramer, Gero ;
Eymard, Jean-Christophe ;
Bamias, Aristotelis ;
Carles, Joan ;
Iacovelli, Roberto ;
Melichar, Bohuslav ;
Sverrisdottir, Asgerdur ;
Theodore, Christine ;
Feyerabend, Susan ;
Helissey, Carole ;
Ozatilgan, Ayse ;
Geffriaud-Ricouard, Christine ;
Castellano, Daniel ;
de Wit, Ronald ;
de Bono, Johann ;
Sternberg, Cora N. ;
Fizazi, Karim ;
Tombal, Bertrand ;
Wulfing, Christian ;
Kramer, Gero ;
Eymard, Jean-Christophe ;
Bamias, Aristotelis ;
Carles, Joan ;
Iacovelli, Roberto ;
Melichar, Bohuslav ;
Sverrisdottir, Asgerour ;
Theodore, Christine ;
Feyerabend, Susan ;
Helissey, Carole ;
Ozatilgan, Ayse ;
Geffriaud-Ricouard, Christine ;
Castellano, Daniel .
NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (26) :2506-2518
[6]   Phase III Study Comparing a Reduced Dose of Cabazitaxel (20 mg/m2) and the Currently Approved Dose (25 mg/m2) in Postdocetaxel Patients With Metastatic Castration-Resistant Prostate Cancer-PROSELICA [J].
Eisenberger, Mario ;
Hardy-Bessard, Anne-Claire ;
Kim, Choung Soo ;
Geczi, Lajos ;
Ford, Daniel ;
Mourey, Loic ;
Carles, Joan ;
Parente, Phillip ;
Font, Albert ;
Kacso, Gabriel ;
Chadjaa, Mustapha ;
Zhang, Wenping ;
Bernard, John ;
de Bono, Johann .
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (28) :3198-+
[7]   Survival with Olaparib in Metastatic Castration-Resistant Prostate Cancer [J].
Hussain, Maha ;
Mateo, Joaquin ;
Fizazi, Karim ;
Saad, Fred ;
Shore, Neal ;
Sandhu, Shahneen ;
Chi, Kim N. ;
Sartor, Oliver ;
Agarwal, Neeraj ;
Olmos, David ;
Thiery-Vuillemin, Antoine ;
Twardowski, Przemyslaw ;
Roubaud, Guilhem ;
Ozguroglu, Mustafa ;
Kang, Jinyu ;
Burgents, Joseph ;
Gresty, Christopher ;
Corcoran, Claire ;
Adelman, Carrie A. ;
de Bono, Johann .
NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (24) :2345-2357
[8]   DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer [J].
Mateo, J. ;
Carreira, S. ;
Sandhu, S. ;
Miranda, S. ;
Mossop, H. ;
Perez-Lopez, R. ;
Rodrigues, D. Nava ;
Robinson, D. ;
Omlin, A. ;
Tunariu, N. ;
Boysen, G. ;
Porta, N. ;
Flohr, P. ;
Gillman, A. ;
Figueiredo, I. ;
Paulding, C. ;
Seed, G. ;
Jain, S. ;
Ralph, C. ;
Protheroe, A. ;
Hussain, S. ;
Jones, R. ;
Elliott, T. ;
McGovern, U. ;
Bianchini, D. ;
Goodall, J. ;
Zafeiriou, Z. ;
Williamson, C. T. ;
Ferraldeschi, R. ;
Riisnaes, R. ;
Ebbs, B. ;
Fowler, G. ;
Roda, D. ;
Yuan, W. ;
Wu, Y. -M. ;
Cao, X. ;
Brough, R. ;
Pemberton, H. ;
A'Hern, R. ;
Swain, A. ;
Kunju, L. P. ;
Eeles, R. ;
Attard, G. ;
Lord, C. J. ;
Ashworth, A. ;
Rubin, M. A. ;
Knudsen, K. E. ;
Feng, F. Y. ;
Chinnaiyan, A. M. ;
Hall, E. .
NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (18) :1697-1708
[9]   Olaparib in patients with metastatic castration-resistant prostate cancer with DNA repair gene aberrations (TOPARP-B): a multicentre, open-label, randomised, phase 2 trial [J].
Mateo, Joaquin ;
Porta, Nuria ;
Bianchini, Diletta ;
McGovern, Ursula ;
Elliott, Tony ;
Jones, Robert ;
Syndikus, Isabel ;
Ralph, Christy ;
Jain, Suneil ;
Varughese, Mohini ;
Parikh, Omi ;
Crabb, Simon ;
Robinson, Angus ;
McLaren, Duncan ;
Birtle, Alison ;
Tanguay, Jacob ;
Miranda, Susana ;
Figueiredo, Ines ;
Seed, George ;
Bertan, Claudia ;
Flohr, Penny ;
Ebbs, Berni ;
Rescigno, Pasquale ;
Fowler, Gemma ;
Ferreira, Ana ;
Riisnaes, Ruth ;
Pereira, Rita ;
Curcean, Andra ;
Chandler, Robert ;
Clarke, Matthew ;
Gurel, Bora ;
Crespo, Mateus ;
Rodrigues, Daniel Nava ;
Sandhu, Shahneen ;
Espinasse, Aude ;
Chatfield, Peter ;
Tunariu, Nina ;
Yuan, Wei ;
Hall, Emma ;
Carreira, Suzanne ;
de Bono, Johann S. .
LANCET ONCOLOGY, 2020, 21 (01) :162-174
[10]   Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer (COU-AA-302): final overall survival analysis of a randomised, double-blind, placebo-controlled phase 3 study [J].
Ryan, Charles J. ;
Smith, Matthew R. ;
Fizazi, Karim ;
Saad, Fred ;
Mulders, Peter F. A. ;
Sternberg, Cora N. ;
Miller, Kurt ;
Logothetis, Christopher J. ;
Shore, Neal D. ;
Small, Eric J. ;
Carles, Joan ;
Flaig, Thomas W. ;
Taplin, Mary-Ellen ;
Higano, Celestia S. ;
de Souza, Paul ;
de Bono, Johann S. s ;
Griffin, Thomas W. ;
De Porre, Peter ;
Yu, Margaret K. ;
Park, Youn C. ;
Li, Jinhui ;
Kheoh, Thian ;
Naini, Vahid ;
Molina, Arturo ;
Rathkopf, Dana E. .
LANCET ONCOLOGY, 2015, 16 (02) :152-160